- Home
- AXSM vs MICC Comparison
AXSM vs MICC Comparison
Compare AXSM & MICC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | MICC |
|---|---|---|
| Founded | 2012 | 2025 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 12.2B |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | AXSM | MICC |
|---|---|---|
| Price | $136.45 | $20.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 22 | 4 |
| Target Price | ★ $271.05 | $19.58 |
| AVG Volume (30 Days) | ★ 1.0M | 831.7K |
| Earning Date | 11-02-2026 | 02-12-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $49.41 | $6.51 |
| Revenue Next Year | $52.53 | $4.35 |
| P/E Ratio | ★ N/A | $28.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $123.00 | $12.94 |
| 52 Week High | $260.19 | $20.69 |
Technical Indicators
Market Signals| Indicator | AXSM | MICC |
|---|---|---|
| Relative Strength Index (RSI) | 26.06 | 54.76 |
| Support Level | N/A | $18.83 |
| Resistance Level | $225.16 | $19.92 |
| Average True Range (ATR) | 7.29 | 0.34 |
| MACD | -0.04 | 0.14 |
| Stochastic Oscillator | 35.37 | 52.67 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About MICC The Magnum Ice Cream Company N.V. Ordinary Shares
The Magnum Ice Cream Co., spun off from Unilever, manufactures and sells a broad portfolio of ice cream brands. The company is a global category leader, operating in 80 countries with around 21% market share. TMICC owns four of the world's five largest ice cream brands: Heartbrand (an umbrella brand with numerous well-known subbrands, which constitutes around 35% of sales), Magnum (23%), Ben & Jerry's (14%), and Cornetto (9%). The business generates about 65% of its revenue in developed markets, with the balance coming from emerging markets.